Syngene International stock shows a positive trend, outperforming the sector by 4.13%

Syngene International, a leading pharmaceutical and pharmaceutical company, witnessed a positive trend in stock performance on October 24, 2024. The stock gained 4.67%, outperforming the sector by 4.13%. This comes after five consecutive days of falling stock prices, indicating a possible trend reversal.

The stock also experienced high volatility with an intraday volatility of 20.35%. However, it managed to hit an intraday high of Rs 873.7, up 4.28% from the previous day’s closing price. The stock’s moving averages are currently above the 5-day, 100-day, and 200-day moving averages, but below the 20- and 50-day moving averages.

MarketsMOJO has issued a “hold” rating on Syngene International shares. This recommendation is based on today’s performance of the stock which has outperformed the Sensex by 4.67% and the one month performance which is -1.99% as compared to -5.71% of the Sensex.

Syngene International is a largecap pharmaceutical and drug industry company. With the recent positive stock performance, the company continues to be a strong player in the market. Investors can keep an eye on the stock’s future performance as it could indicate potential growth for the company.